Brief: Dmk Pharmaceuticals Corp Received Superseding Notice From Nasdaq, Indicating That The Prior Notice Was Issued In Error
19/10/2023 22:26
Oct 19 (Reuters) -
* DMK PHARMACEUTICALS CORP- ON OCT 18, CO RECEIVED
SUPERSEDING
NOTICE FROM NASDAQ, INDICATING THAT THE PRIOR NOTICE WAS ISSUED
IN ERROR
* DMK PHARMACEUTICALS- SUBSEQUENT NOTICE SAID CO WAS NOT
ELIGIBLE
FOR AUTOMATIC 180-DAY COMPLIANCE GRACE PERIOD PROVIDED BY
LISTING RULE 5810(C)(3)(A)
Further company coverage: DMK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DMK Pharmaceuticals
See all newsBrief: Dmk Pharmaceuticals Corp Says Ebrahim Versi Resigned As Chairman
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update